Hemrajani Rekha 4
4 · MAXCYTE, INC. · Filed Aug 27, 2025
Insider Transaction Report
Form 4
MAXCYTE, INC.MXCT
Hemrajani Rekha
Director
Transactions
- Sale
Common Stock
2025-06-25$2.09/sh−10,684$22,378→ 39,893 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2025.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.07 to $2.1212, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.